ESR1 and breast cancer: The present study showed that targets of Chrysanthemum phytochemicals (luteolin, chlorogenic acid, rutin, quercetin, and apigenin) belong to estrogen receptors such as ESR1, ESR2, and PGR and are major therapeutic targets of breast cancer.